BackTRACON Pharmaceuticals Overview

TRACON Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for TCON.

Quarterly SG&A Expenses

$1.62M
↓ 15.61% YoY

As of Jun 30, 2024

Annual SG&A Expenses (TTM)

$5.46M
↓ 35.78% YoY

Trailing 12 months ending Jun 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin